MedTrace Logo

The Effect of Mindfulness-Based Self-Compassion Training on Childbirth Fear, Pregnancy Stress, and Comfort in Primiparous Women

NCT07548528 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-04-23

No results posted yet for this study

Summary

The purpose of this study was to determine the effects of mindfulness-based self-compassion training provided to primiparous women on fear of childbirth, pregnancy stress, and comfort.

Research Hypotheses H1a: Mindfulness-based self-compassion training provided to primiparous women reduces fear of childbirth.

H1b: Mindfulness-based self-compassion training provided to primiparous women reduces pregnancy stress.

H1c: Mindfulness-based self-compassion training provided to primiparous women increases comfort.

Conditions

  • Pregnancy Related

Interventions

OTHER

self-compassion training

As a midwifery intervention, primiparous women in the experimental group were provided with mindfulness-based self-compassion training. The self-compassion training program consisted of encouraging women to be kind and understanding toward themselves, recognizing that suffering is a part of human life and that being present in the here and now contributes to the human spirit and consciousness, providing a discussion environment for sharing their experiences, and homework assignments related to the program content. The researcher conducted an eight-week mindfulness-based self-compassion training. The training program will be conducted in six sessions, using face-to-face meetings at the pregnancy school. While the duration of each session will vary depending on the women's compliance and needs, each session is planned to last approximately 30-40 minutes. The mindfulness-based self-compassion training will be implemented by the researcher. Each session will cover an introduction to self-c

Sponsors & Collaborators

  • Inonu University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-30
Primary Completion
2026-08-31
Completion
2026-08-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07548528 on ClinicalTrials.gov